Hachamovitch Rory, Hayes Sean W, Friedman John D, Cohen Ishac, Berman Daniel S
Department of Imaging, Cedars-Sinai Medical Center, University of California Los Angeles School of Medicine, Los Angeles, Calif 90048, USA.
Circulation. 2003 Jun 17;107(23):2900-7. doi: 10.1161/01.CIR.0000072790.23090.41. Epub 2003 May 27.
The relationship between the amount of inducible ischemia present on stress myocardial perfusion single photon emission computed tomography (myocardial perfusion stress [MPS]) and the presence of a short-term survival benefit with early revascularization versus medical therapy is not clearly defined.
A total of 10 627 consecutive patients who underwent exercise or adenosine MPS and had no prior myocardial infarction or revascularization were followed up (90.6% complete; mean: 1.9+/-0.6 years). Cardiac death occurred in 146 patients (1.4%). Treatment received within 60 days after MPS defined subgroups undergoing revascularization (671 patients, 2.8% mortality) or medical therapy (MT) (9956 patients, 1.3% mortality; P=0.0004). To adjust for nonrandomization of treatment, a propensity score was developed using logistic regression to model the decision to refer to revascularization. This model (chi2=1822, c index=0.94, P<10-7) identified inducible ischemia and anginal symptoms as the most powerful predictors (83%, 6% of overall chi2) and was incorporated into survival models. On the basis of the Cox proportional hazards model predicting cardiac death (chi2=539, P<0.0001), patients undergoing MT demonstrated a survival advantage over patients undergoing revascularization in the setting of no or mild ischemia, whereas patients undergoing revascularization had an increasing survival benefit over patients undergoing MT when moderate to severe ischemia was present. Furthermore, increasing survival benefit for revascularization over MT was noted in higher risk patients (elderly, adenosine stress, and women, especially those with diabetes).
Revascularization compared with MT had greater survival benefit (absolute and relative) in patients with moderate to large amounts of inducible ischemia. These findings have significant consequences for future approaches to post-single photon emission computed tomography patient management if confirmed by prospective evaluations.
负荷心肌灌注单光子发射计算机断层扫描(心肌灌注负荷显像 [MPS])显示的可诱导性心肌缺血量与早期血运重建术和药物治疗相比的短期生存获益之间的关系尚未明确界定。
对总共10627例连续接受运动或腺苷MPS检查且既往无心肌梗死或血运重建术的患者进行随访(90.6% 完整随访;平均:1.9±0.6年)。146例患者(1.4%)发生心源性死亡。根据MPS检查后60天内接受的治疗将患者分为接受血运重建术的亚组(671例患者,死亡率2.8%)或药物治疗(MT)亚组(9956例患者,死亡率1.3%;P=0.0004)。为校正治疗的非随机化,采用逻辑回归建立倾向评分模型以模拟转至血运重建术的决策。该模型(χ2=1822,c指数=0.94,P<10-7)确定可诱导性心肌缺血和心绞痛症状为最有力的预测因素(占总χ2的83%、6%),并纳入生存模型。基于预测心源性死亡的Cox比例风险模型(χ2=539,P<0.0001),在无或轻度缺血情况下,接受MT治疗的患者比接受血运重建术的患者具有生存优势,而在存在中度至重度缺血时,接受血运重建术的患者比接受MT治疗的患者具有更大的生存获益。此外,在高危患者(老年人、腺苷负荷试验、女性,尤其是糖尿病女性)中,血运重建术相对于MT的生存获益增加更为明显。
与MT相比,血运重建术在中度至大量可诱导性心肌缺血患者中具有更大的生存获益(绝对和相对)。如果前瞻性评估证实这些发现,将对单光子发射计算机断层扫描后患者管理的未来方法产生重大影响。